Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Gossamer Bio Inc (NASDAQ: GOSS) closed at $1.98 in the last session, down -8.33% from day before closing price of $2.16. In other words, the price has decreased by -$8.33 from its previous closing price. On the day, 3.97 million shares were traded. GOSS stock price reached its highest trading level at $2.21 during the session, while it also had its lowest trading level at $1.92.
Ratios:
We take a closer look at GOSS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 4.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on July 14, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $11.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 450057952 and an Enterprise Value of 439123616. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.19. Its current Enterprise Value per Revenue stands at 10.913 whereas that against EBITDA is -3.022.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.94, which has changed by 1.4235005 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $2.23, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 33.88%, while the 200-Day Moving Average is calculated to be 77.26%.
Shares Statistics:
According to the various share statistics, GOSS traded on average about 2.41M shares per day over the past 3-months and 3574740 shares per day over the past 10 days. A total of 227.32M shares are outstanding, with a floating share count of 182.66M. Insiders hold about 19.64% of the company’s shares, while institutions hold 58.98% stake in the company. Shares short for GOSS as of 1752537600 were 18122038 with a Short Ratio of 7.51, compared to 1749772800 on 11076527. Therefore, it implies a Short% of Shares Outstanding of 18122038 and a Short% of Float of 8.49.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Gossamer Bio Inc (GOSS) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.18 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.7 and -$0.77 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.46, with 8.0 analysts recommending between -$0.11 and -$0.89.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for GOSS’s current fiscal year. The highest revenue estimate was $31.4M, while the lowest revenue estimate was $21.38M, resulting in an average revenue estimate of $27.34M. In the same quarter a year ago, actual revenue was $114.7M
